Intranasal administration of IL-35 inhibits allergic responses and symptoms in mice with allergic rhinitis

Allergology International

Volumn 66, Issue 2, 2017, Pages 351-356

  Suzuki, Motohiko ^a   Yokota, Makoto ^a   Nakamura, Yoshihisa ^a   Ozaki, Shinya ^a   Murakami, Shingo ^a  

^a NAGOYA CITY UNIVERSITY   (Japan)

Author keywords

Allergic rhinitis; Cervical lymph node; IL 10; IL 35; Regulatory T cell

Indexed keywords

IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; INTERLEUKIN 10; INTERLEUKIN 35; INTERLEUKIN 4; INTERLEUKIN 5; OVALBUMIN; RECOMBINANT CYTOKINE; RECOMBINANT INTERLEUKIN 35 IMMUNOGLOBULIN G1 FC FRAGMENT FUSION PROTEIN; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG; CYTOKINE; HYBRID PROTEIN; IMMUNOGLOBULIN G; INTERLEUKIN DERIVATIVE; INTERLEUKIN-35, MOUSE;

ALLERGIC RHINITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELLULAR IMMUNITY; CERVICAL LYMPH NODE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; EOSINOPHIL COUNT; EOSINOPHILIA; GENE EXPRESSION; GENETIC TRANSCRIPTION; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; NOSE MUCOSA; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SENSITIZATION; SNEEZING; SYMPTOM; T LYMPHOCYTE; ANIMAL; BIOSYNTHESIS; BLOOD; DISEASE MODEL; IMMUNOLOGY; INTRANASAL DRUG ADMINISTRATION; LYMPHOCYTE ACTIVATION; METABOLISM; PATHOLOGY; PHENOTYPE; RHINITIS, ALLERGIC; T LYMPHOCYTE SUBPOPULATION; TREATMENT OUTCOME;

ADMINISTRATION, INTRANASAL; ANIMALS; CYTOKINES; DISEASE MODELS, ANIMAL; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERLEUKINS; LYMPHOCYTE ACTIVATION; MALE; MICE; NASAL MUCOSA; PHENOTYPE; RECOMBINANT FUSION PROTEINS; RHINITIS, ALLERGIC; T-LYMPHOCYTE SUBSETS; TREATMENT OUTCOME;

EID: 84994388505     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.1016/j.alit.2016.08.014     Document Type: Article

References (35)

1. 1 Aluvihare, V.R., Kallikourdis, M., Betz, A.G., Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol 5 (2004), 266–271.
2. 2 Suzuki, M., Zheng, X., Zhang, X., Zhang, Z.X., Ichim, T.E., Sun, H., et al. A novel allergen-specific therapy for allergy using CD40-silenced dendritic cells. J Allergy Clin Immunol 125 (2010), 737–743.
3. 3 Suzuki, M., Zheng, X., Zhang, X., Li, M., Vladau, C., Ichim, T.E., et al. Novel vaccination for allergy through gene silencing of CD40 using small interfering RNA. J Immunol 180 (2008), 8461–8469.
4. 4 Kearley, J., Robinson, D.S., Lloyd, C.M., CD4+CD25+ regulatory T cells reverse established allergic airway inflammation and prevent airway remodeling. J Allergy Clin Immunol 122 (2008), 617–624.
5. 5 Collison, L.W., Workman, C.J., Kuo, T.T., Boyd, K., Wang, Y., Vignali, K.M., et al. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 450 (2007), 566–569.
6. 6 Wang, W., Li, P., Chen, Y.F., Yang, J., A potential immunopathogenic role for reduced IL-35 expression in allergic asthma. J Asthma 52 (2015), 763–771.
7. 7 Whitehead, G.S., Wilson, R.H., Nakano, K., Burch, L.H., Nakano, H., Cook, D.N., IL-35 production by inducible costimulator (ICOS)-positive regulatory T cells reverses established IL-17-dependent allergic airways disease. J Allergy Clin Immunol 129 (2012), 207–215.
8. 8 Huang, C.H., Loo, E.X., Kuo, I.C., Soh, G.H., Goh, D.L., Lee, B.W., et al. Airway inflammation and IgE production induced by dust mite allergen-specific memory/effector Th2 cell line can be effectively attenuated by IL-35. J Immunol 187 (2011), 462–471.
9. 9 Dong, J., Wong, C.K., Cai, Z., Jiao, D., Chu, M., Lam, C.W., Amelioration of allergic airway inflammation in mice by regulatory IL-35 through dampening inflammatory dendritic cells. Allergy 70 (2015), 921–932.
10. 10 Li, Y., Pan, X., Peng, X., Li, S., Zhou, Y., Zheng, X., et al. Adenovirus-mediated interleukin-35 gene transfer suppresses allergic airway inflammation in a murine model of asthma. Inflamm Res 64 (2015), 767–774.
11. 11 Yokota, M., Suzuki, M., Nakamura, Y., Ozaki, S., Murakami, S., Cytokine modulation by IL-35 in mice with allergic rhinitis. Am J Rhinol Allergy 29 (2015), 251–256.
12. 12 Li, M., Zhang, X., Zheng, X., Lian, D., Zhang, Z.X., Ge, W., et al. Immune modulation and tolerance induction by RelB-silenced dendritic cells through RNA interference. J Immunol 178 (2007), 5480–5487.
13. 13 Devergne, O., Coulomb-L'Hermine, A., Capel, F., Moussa, M., Capron, F., Expression of Epstein-Barr virus-induced gene 3, an interleukin-12 p40-related molecule, throughout human pregnancy: involvement of syncytiotrophoblasts and extravillous trophoblasts. Am J Pathol 159 (2001), 1763–1776.
14. 14 Collison, L.W., Pillai, M.R., Chaturvedi, V., Vignali, D.A., Regulatory T cell suppression is potentiated by target T cells in a cell contact, IL-35- and IL-10-dependent manner. J Immunol 182 (2009), 6121–6128.
15. 15 Collison, L.W., Chaturvedi, V., Henderson, A.L., Giacomin, P.R., Guy, C., Bankoti, J., et al. IL-35-mediated induction of a potent regulatory T cell population. Nat Immunol 11 (2010), 1093–1101.
16. 16 Niedbala, W., Wei, X.Q., Cai, B., Hueber, A.J., Leung, B.P., McInnes, I.B., et al. IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells. Eur J Immunol 37 (2007), 3021–3029.
17. 17 Kato, Y., Akasaki, S., Muto-Haenuki, Y., Fujieda, S., Matsushita, K., Yoshimoto, T., Nasal sensitization with ragweed pollen induces local-allergic-rhinitis-like symptoms in mice. PLoS One, 9, 2014, e103540.
18. 18 Wills-Karp, M., Luyimbazi, J., Xu, X., Schofield, B., Neben, T.Y., Karp, C.L., et al. Interleukin-13: central mediator of allergic asthma. Science 282 (1998), 2258–2261.
19. 19 Snapper, C.M., Finkelman, F.D., Stefany, D., Conrad, D.H., Paul, W.E., IL-4 induces co-expression of intrinsic membrane IgG1 and IgE by murine B cells stimulated with lipopolysaccharide. J Immunol 141 (1988), 489–498.
20. 20 Hamelmann, E., Gelfand, E.W., IL-5-induced airway eosinophilia–the key to asthma?. Immunol Rev 179 (2001), 182–191.
21. 21 Fu, C.L., Ye, Y.L., Lee, Y.L., Chiang, B.L., Effects of overexpression of IL-10, IL-12, TGF-beta and IL-4 on allergen induced change in bronchial responsiveness. Respir Res, 7, 2006, 72.
22. 22 Baumann, R., Rabaszowski, M., Stenin, I., Tilgner, L., Scheckenbach, K., Wiltfang, J., et al. Comparison of the nasal release of IL-4, IL-10, IL-17, CCL13/MCP-4, and CCL26/eotaxin-3 in allergic rhinitis during season and after allergen challenge. Am J Rhinol Allergy 27 (2013), 266–272.
23. 23 Murai, M., Turovskaya, O., Kim, G., Madan, R., Karp, C.L., Cheroutre, H., et al. Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis. Nat Immunol 10 (2009), 1178–1184.
24. 24 Chen, W., Jin, W., Hardegen, N., Lei, K.J., Li, L., Marinos, N., et al. Conversion of peripheral CD4+CD25− naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 198 (2003), 1875–1886.
25. 25 Yamada, T., Tongu, M., Goda, K., Aoi, N., Morikura, I., Fuchiwaki, T., et al. Sublingual immunotherapy induces regulatory function of il-10-expressing CD4(+)CD25(+)Foxp3(+) T cells of cervical lymph nodes in murine allergic rhinitis model. J Allergy (Cairo), 2012, 2012, 490905.
26. 26 Wilson, D.R., Lima, M.T., Durham, S.R., Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis. Allergy 60 (2005), 4–12.
27. 27 Hsu, P., Santner-Nanan, B., Hu, M., Skarratt, K., Lee, C.H., Stormon, M., et al. IL-10 potentiates differentiation of human induced regulatory T cells via STAT3 and Foxo1. J Immunol 195 (2015), 3665–3674.
28. 28 Zheng, S.G., Wang, J., Wang, P., Gray, J.D., Horwitz, D.A., IL-2 is essential for TGF-beta to convert naive CD4+CD25− cells to CD25+Foxp3+ regulatory T cells and for expansion of these cells. J Immunol 178 (2007), 2018–2027.
29. 29 Maruyama, T., Konkel, J.E., Zamarron, B.F., Chen, W., The molecular mechanisms of Foxp3 gene regulation. Semin Immunol 23 (2011), 418–423.
30. 30 Burchill, M.A., Yang, J., Vogtenhuber, C., Blazar, B.R., Farrar, M.A., IL-2 receptor beta-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells. J Immunol 178 (2007), 280–290.
31. 31 Haeryfar, S.M., DiPaolo, R.J., Tscharke, D.C., Bennink, J.R., Yewdell, J.W., Regulatory T cells suppress CD8+ T cell responses induced by direct priming and cross-priming and moderate immunodominance disparities. J Immunol 174 (2005), 3344–3351.
32. 32 Boettler, T., Spangenberg, H.C., Neumann-Haefelin, C., Panther, E., Urbani, S., Ferrari, C., et al. T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection. J Virol 79 (2005), 7860–7867.
33. 33 Terrada, C., Fisson, S., De Kozak, Y., Kaddouri, M., Lehoang, P., Klatzmann, D., et al. Regulatory T cells control uveoretinitis induced by pathogenic Th1 cells reacting to a specific retinal neoantigen. J Immunol 176 (2006), 7171–7179.
34. 34 Cecere, T.E., Todd, S.M., Leroith, T., Regulatory T cells in arterivirus and coronavirus infections: do they protect against disease or enhance it?. Viruses 4 (2012), 833–846.
35. 35 Anghelina, D., Zhao, J., Trandem, K., Perlman, S., Role of regulatory T cells in coronavirus-induced acute encephalitis. Virology 385 (2009), 358–367.